Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
Terpos E, Tasidou A, Eleftherakis-Papaiakovou E, Christoulas D, Gavriatopoulou M, Gkotzamanidou M, Roussou M, Kastritis E, Papadaki T, Dimopoulos MA. Terpos E, et al. Among authors: eleftherakis papaiakovou e. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):115-7. doi: 10.3816/CLML.2011.n.024. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21454208
Angiogenesis in Waldenström's macroglobulinemia.
Terpos E, Tasidou A, Kastritis E, Eleftherakis-Papaiakovou E, Gavriatopoulou M, Migkou M, Dimopoulos MA. Terpos E, et al. Among authors: eleftherakis papaiakovou e. Clin Lymphoma Myeloma. 2009 Mar;9(1):46-9. doi: 10.3816/CLM.2009.n.011. Clin Lymphoma Myeloma. 2009. PMID: 19362971 Review.
[No title available]
[No authors listed] [No authors listed] PMID: 36164178
Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.
Liontos M, Kastritis E, Markellos C, Migkou M, Eleftherakis-Papaiakovou E, Koutsoukos K, Gavriatopoulou M, Zagouri F, Psaltopoulou T, Terpos E, Dimopoulos MA. Liontos M, et al. Among authors: eleftherakis papaiakovou e. Cancers (Basel). 2021 Feb 12;13(4):763. doi: 10.3390/cancers13040763. Cancers (Basel). 2021. PMID: 33673120 Free PMC article.
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.
Paschou SA, Liontos M, Eleftherakis-Papaiakovou E, Stefanaki K, Markellos C, Koutsoukos K, Zagouri F, Psaltopoulou T, Dimopoulos MA. Paschou SA, et al. Among authors: eleftherakis papaiakovou e. Front Oncol. 2022 Mar 24;12:847917. doi: 10.3389/fonc.2022.847917. eCollection 2022. Front Oncol. 2022. PMID: 35402216 Free PMC article.
Cardiac mechanics in response to proteasome inhibition: a prospective study.
Makris N, Georgiopoulos G, Laina A, Tselegkidi ME, Fotiou D, Kanellias N, Eleftherakis-Papaiakovou E, Migkou M, Papanagnou ED, Katogiannis K, Petropoulos I, Anninos H, Bampatsias D, Maneta E, Samouilidou E, Nikas D, Ciliberti G, Stellos K, Terpos E, Gavriatopoulou M, Trougakos IP, Ikonomidis I, Dimopoulos MA, Kastritis E, Stamatelopoulos K. Makris N, et al. Among authors: eleftherakis papaiakovou e. Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):643-652. doi: 10.1093/ehjci/jeac168. Eur Heart J Cardiovasc Imaging. 2023. PMID: 35980754
Rare manifestations of extramedullary myeloma: testicular plasmacytomas.
Ntanasis-Stathopoulos I, Gavriatopoulou M, Eleftherakis-Papaiakovou E, Kastritis E, Terpos E, Dimopoulos MA. Ntanasis-Stathopoulos I, et al. Among authors: eleftherakis papaiakovou e. Leuk Lymphoma. 2018 Aug;59(8):2002-2004. doi: 10.1080/10428194.2017.1410887. Epub 2017 Dec 7. Leuk Lymphoma. 2018. PMID: 29214871 No abstract available.
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease.
Kastritis E, Terpos E, Moulopoulos L, Spyropoulou-Vlachou M, Kanellias N, Eleftherakis-Papaiakovou E, Gkotzamanidou M, Migkou M, Gavriatopoulou M, Roussou M, Tasidou A, Dimopoulos MA. Kastritis E, et al. Among authors: eleftherakis papaiakovou e. Leukemia. 2013 Apr;27(4):947-53. doi: 10.1038/leu.2012.309. Epub 2012 Nov 6. Leukemia. 2013. PMID: 23183429
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis.
Terpos E, Kastritis E, Roussou M, Heath D, Christoulas D, Anagnostopoulos N, Eleftherakis-Papaiakovou E, Tsionos K, Croucher P, Dimopoulos MA. Terpos E, et al. Among authors: eleftherakis papaiakovou e. Leukemia. 2008 Dec;22(12):2247-56. doi: 10.1038/leu.2008.235. Epub 2008 Sep 4. Leukemia. 2008. PMID: 18769451 Clinical Trial.
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.
Dimopoulos MA, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E, Bamias A. Dimopoulos MA, et al. Among authors: eleftherakis papaiakovou e. Ann Oncol. 2009 Jan;20(1):117-20. doi: 10.1093/annonc/mdn554. Epub 2008 Aug 9. Ann Oncol. 2009. PMID: 18689864 Free article.